Cetera Investment Advisers
Position in CATX — Perspective Therapeutics, Inc.
CIK 1666741
SCHAUMBURG, IL
Position in CATX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$34,754
+$19,879 QoQ
Shares Held
10,192
+715.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 130 holders
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $230,407,971 across 39 Medical Devices names. CATX ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
181,223 | $57,056,249 | |
| 2 | ABT |
Abbott Laboratories
|
619,756 | $56,236,659 | |
| 3 | MDT |
Medtronic plc
|
618,387 | $48,376,415 | |
| 4 | BSX |
Boston Scientific Corp
|
462,281 | $19,730,153 | |
| 5 | EW |
Edwards Lifesciences Corp
|
105,195 | $9,515,939 | |
| 6 | DXCM |
Dexcom Inc
|
126,816 | $8,541,057 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
79,315 | $5,076,953 | |
| 8 | GMED |
Globus Medical Inc
|
51,719 | $4,086,318 |
All Filings in CATX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,754 | 10,192 | Shares | Sole | 2026-08-12 | |
| 2024-03-31 | $14,875 | 12,500 | Shares | Sole | 2024-05-24 | |
| 2023-09-30 | $17,550 | 65,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $43,550 | 65,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $54,400 | 85,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,250 | 85,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||